Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guarneri

Showing results (1191-1200 of 1,433) with videos related to

Pageof 144
Sort By:
Breast Cancer Research and Treatment|February 25, 2016
Whole exome sequencing of rare aggressive breast cancer histologiesMaria Vittoria Dieci, Veronika Smutná, Véronique Scott, et al.
The Oncologist|July 4, 2020
Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast CancerFederica Miglietta, Maria Vittoria Dieci, Vassilena Tsvetkova, et al.
Medicine|June 3, 2020
Utility of neutrophil-to-lymphocyte ratio to identify long-term survivors among HCC patients treated with sorafenibAndrea Casadei-Gardini, Vincenzo Dadduzio, Giulia Rovesti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2007
Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in patients with taxane-resistant metastatic breast cancerEva Thomas, Josep Tabernero, Monica Fornier, et al.
Frontiers in Oncology|September 26, 2022
Controversial topics in metastatic HR+/HER2- breast cancer: Guiding treatment by a modified Delphi approachAlessandra Fabi, Giuseppe Buono, Emilio Bria, et al.
The Breast Journal|December 15, 2019
Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective studyTommaso Giarratano, Simona Frezzini, Monica Zanocco, et al.
Wiener Medizinische Wochenschrift (1946)|January 16, 2013
Atypical fibroxanthoma-a diagnosis of exclusion!Georgi Tchernev, Michael Tronnier, Julian Ananiev, et al.
The Pharmacogenomics Journal|July 6, 2016
Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancerA Musolino, N Naldi, M V Dieci, et al.
Oncotarget|April 19, 2017
GD2 expression in breast cancerGiulia Orsi, Monica Barbolini, Guido Ficarra, et al.
Cardiovascular Diabetology|August 31, 2025
Coronary flow reserve increase after 4-year dapagliflozin treatment in patients with type 2 diabetes: the DAPAHEART follow-up studyFrancesca Cinti, Cassandra Morciano, Andrea Guarneri, et al.
Pageof 144

Showing results (1191-1200 of 1,433) with videos related to

Sort By:
Pageof 144
Breast Cancer Research and Treatment|February 25, 2016
Whole exome sequencing of rare aggressive breast cancer histologiesMaria Vittoria Dieci, Veronika Smutná, Véronique Scott, et al.
The Oncologist|July 4, 2020
Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast CancerFederica Miglietta, Maria Vittoria Dieci, Vassilena Tsvetkova, et al.
Medicine|June 3, 2020
Utility of neutrophil-to-lymphocyte ratio to identify long-term survivors among HCC patients treated with sorafenibAndrea Casadei-Gardini, Vincenzo Dadduzio, Giulia Rovesti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2007
Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in patients with taxane-resistant metastatic breast cancerEva Thomas, Josep Tabernero, Monica Fornier, et al.
Frontiers in Oncology|September 26, 2022
Controversial topics in metastatic HR+/HER2- breast cancer: Guiding treatment by a modified Delphi approachAlessandra Fabi, Giuseppe Buono, Emilio Bria, et al.
The Breast Journal|December 15, 2019
Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective studyTommaso Giarratano, Simona Frezzini, Monica Zanocco, et al.
Wiener Medizinische Wochenschrift (1946)|January 16, 2013
Atypical fibroxanthoma-a diagnosis of exclusion!Georgi Tchernev, Michael Tronnier, Julian Ananiev, et al.
The Pharmacogenomics Journal|July 6, 2016
Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancerA Musolino, N Naldi, M V Dieci, et al.
Oncotarget|April 19, 2017
GD2 expression in breast cancerGiulia Orsi, Monica Barbolini, Guido Ficarra, et al.
Cardiovascular Diabetology|August 31, 2025
Coronary flow reserve increase after 4-year dapagliflozin treatment in patients with type 2 diabetes: the DAPAHEART follow-up studyFrancesca Cinti, Cassandra Morciano, Andrea Guarneri, et al.
Pageof 144